Figure 1.
Strategy for selecting patients from the COLT (COhort of Lung Transplantation).
*Emphysema, Sarcoïdosis, Lymphangiomatosis, Secondary PAH, histiocytosis, fibrosis, bronchiectasis and COPD (Chronic Obstructive Pulmonary Disease). CF: Cystic Fibrosis; PAH: Pulmonary Arterial hypertension; COPD: Chronic Obstructive Pulmonary Disease. Patients were excluded during the RNA process following specific qualities criteria.
Table 1.
Summary of clinical data of patients included in the microarray (A) and in the validation (B) cohorts.
Figure 2.
Unsupervised hierarchical clustering analysis.
A) Tree analysis. Clustering analysis based on the 30,146 probes corresponding to 17,163 unique genes expressed in PAH, CF patients and Healthy Controls (HC). 3 signatures were found: 1 common between CF and PAH (named CRD signature), 1 specific to CF and 1 to PAH; B) Principal Component Analysis (PCA) displayed a clear separation between HC and patients with CRD, whereas CF and PAH patients were less distinct; C) 5 groups of genes (or clusters) were selected, A to E, based on a combined approach: selected genes were clustered together and exhibited a t-test p-value below 1% between the CRD group (PAH+CF), CF or PAH versus HC. Green represents relatively low expression, and red indicates relatively high expression.
Figure 3.
Characterization of under-expressed genes in the CRD signature.
A) Tree analysis of the CRD signature. Identification of the most representative genes by Gominer, PAM, IPA analysis and validation of the candidate genes in the validation cohort by qPCR; B) Network generated by IPA on the most significant GO categories in the CRD signature. Solid lines indicate direct interactions and dashed lines represent indirect interactions. Under-expressed genes in CRD are in gray. C) PAM analysis based on the most representative GO categories of Cluster A and B. Green represents relatively low expression, and red indicates relatively high expression. D) List of 9 genes able to classify correctly CRD and HC. E) The PCA graph of the 9 genes identified by PAM analysis indicated a clear separation between HC and patients with CRD (CF and PAH).
Table 2.
Gene Ontology (GO categories) for genes in CRD signature versus HC.
Figure 4.
Validation of the most representative genes in the validation cohort.
A) Quantitative PCR validation of 3 genes from the PAM analysis (IL-7R, TCF-7 and CD6) using the validation cohort; B) based on these qPCR values, IL-7R and TCF-7 enabled good discrimination between patients with CRD and HC, according to a receiver operating characteristic (ROC) analysis (AUC = 89.6% with p<0.001 and AUC = 89.4% with p<0.001, respectively); C) Median intensity fluorescence (MFI) and mRNA expression of IL-7R in PBMCs from healthy controls (HC) cultivated 12 hours under hypoxic and normoxic condition; D) MFI of IL-7R on PBMCs from CRD patients compared to HC; E) TCF-7 expression in PBMCs from HC under hypoxia or normoxia.
Figure 5.
Characterization of over-expressed genes in the PAH signature.
A) Tree analysis of the PAH signature. Identification of the most representative genes by Gominer, PAM, IPA analysis and validation by qPCR of the candidate genes in the validation cohort; B) Network generated by IPA on the most significant GO categories in PAH signature. Over-expressed genes in PAH are in gray. C) PAM analysis based on the cluster, Green represents relatively low expression, and red indicates relatively high expression; D and E) Validation by qPCR of MDK and LGALS3 in the validation cohort, respectively.
Table 3.
Gominer Analysis based for over-expressed genes in PAH signature versus HC.
Figure 6.
Characterization of over-expressed genes in the CF signature.
A) Tree analysis of CF signature. Identification of the most representative genes by Gominer and IPA analysis and validation by qPCR of these genes in the validation cohort; B) Network generated by IPA on the most significant GO categories in CF signature. Over-expressed genes in CF are in gray; C, D, E) qPCR validation on the new cohort for NLRC4, TLR8 and TLR4 genes.
Table 4.
Gominer Analysis based for over-expressed genes in CF signature versus HC.